BioAge Labs, Inc. (BIOA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BioAge Labs, Inc. reported revenue of $8.99M. The company ran a net loss, with a net margin of -896.1%. It held $294.89M in total assets against $22.84M in total liabilities.
Key ratios (FY2025)
-1031.5%
Operating margin
-896.1%
Net margin
-29.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $8.99M | $0 | — | — |
| Operating Income | -$92.78M | -$78.19M | -$48.40M | — |
| Net Income | -$80.61M | -$71.11M | -$63.85M | — |
| EPS (Diluted) | $-2.24 | $-6.63 | $-38.17 | — |
| Total Assets | $294.89M | $358.23M | $25.92M | — |
| Total Liabilities | $22.84M | $35.11M | $66.60M | — |
| Shareholders' Equity | $272.05M | $323.13M | -$173.40M | -$112.56M |
| Cash & Equivalents | $188.89M | $354.35M | $21.64M | — |
| Operating Cash Flow | -$81.63M | -$51.52M | -$37.36M | — |
| Capital Expenditures | $719.0K | $366.0K | $166.0K | — |
| Shares Outstanding | 37.39M | 35.85M | 1.67M | — |